Trevi Therapeutics to Participate in Upcoming February Investor Conferences
NEW HAVEN, Conn., Jan. 30, 2025 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage…
PR Newswire is a distributor of press releases headquartered in New York City.